Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate.

Galgani JE, Heilbronn LK, Azuma K, Kelley DE, Albu JB, Pi-Sunyer X, Smith SR, Ravussin E; Look AHEAD Adipose Research Group..

Diabetes. 2008 Apr;57(4):841-5. doi: 10.2337/db08-0043.

2.

The contribution of race and diabetes status to metabolic flexibility in humans.

Stull AJ, Galgani JE, Johnson WD, Cefalu WT.

Metabolism. 2010 Sep;59(9):1358-64. doi: 10.1016/j.metabol.2009.12.020.

3.

Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.

Yokoyama H, Emoto M, Mori K, Araki T, Teramura M, Koyama H, Shoji T, Inaba M, Nishizawa Y.

J Clin Endocrinol Metab. 2006 Jan;91(1):290-4.

PMID:
16234307
4.

Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).

Vaag A, Lehtovirta M, Thye-Rönn P, Groop L; European Group of Insulin Resistance..

Diabet Med. 2001 Jul;18(7):533-40.

PMID:
11553181
5.
6.

Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action.

Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Mandarino LJ.

J Appl Physiol (1985). 2003 Dec;95(6):2519-29.

7.

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.

Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH, Rewers M.

Diabetes. 2011 Jan;60(1):306-14. doi: 10.2337/db10-0328.

8.

In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.

Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA.

Diabetes. 1993 May;42(5):764-72.

PMID:
8482434
9.

Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.

Kelley DE, Mokan M, Mandarino LJ.

Diabetes Care. 1993 Aug;16(8):1158-66.

PMID:
8375246
10.

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285.

PMID:
8621019
11.

Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects.

Lara-Castro C, Newcomer BR, Rowell J, Wallace P, Shaughnessy SM, Munoz AJ, Shiflett AM, Rigsby DY, Lawrence JC, Bohning DE, Buchthal S, Garvey WT.

Metabolism. 2008 Jan;57(1):1-8.

12.

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.

Diabetes. 2001 Aug;50(8):1844-50.

14.

Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes.

Albu JB, Heilbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, Pi-Sunyer FX, Ravussin E; Look AHEAD Adipose Research Group..

Diabetes. 2010 Mar;59(3):627-33. doi: 10.2337/db09-1239.

15.

Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation.

Båvenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, Efendic S.

J Clin Endocrinol Metab. 2003 Jan;88(1):82-7. Erratum in: J Clin Endocrinol Metab. 2003 May;88(5):2036.

PMID:
12519834
16.

Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.

Weyer C, Tataranni PA, Snitker S, Danforth E Jr, Ravussin E.

Diabetes. 1998 Oct;47(10):1555-61.

PMID:
9753292
17.
18.

Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E.

Diabetes. 2001 Aug;50(8):1807-12.

19.

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.

Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA.

Diabetes. 1987 Nov;36(11):1341-50.

PMID:
3311856
20.

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

Diabetes. 2000 Jul;49(7):1209-18.

PMID:
10909980

Supplemental Content

Support Center